Ian Keith Smith BSc (Hons) (Executive Chairman)
Keith has a Bachelor of Science (Honours) degree from Massey University. He has more than twenty years experience in the pharmaceutical and biotechnology industry including senior business development and R&D management roles in a major international pharmaceutical company. He has led the development of a number of drugs including product taken through the US NDA regulatory pathway and the progression of an early stage biopharmaceutical through to phase I. Other business experience includes opportunity analysis, business development and licensing. More recently, Keith established Virient Pty Ltd, a consulting firm serving the pharmaceutical and biotechnology industry. Keith is also a director of Atherogen Biotechnology Pty Ltd, and a director of the charity, the Neil Sachse Foundation. Keith is an inventor on a number of patents and he is a member of the Federal Government Advisory Council on Intellectual Property, member of the Advisory Board, Ian Wark Research Institute, and partner of the Innovative Centre for Drug Formulation and Delivery, University of South Australia.

Douglas Peter LeMessurier
SIA(Aff) ADA1(ASX) MSDIA MBA
Peter is a sharebroker. Previously, he has held positions as State Manager of D&D Tolhurst Ltd – South Australia, a national share broking firm, and as director of the South Australian Asset Management Corporation (Chair of Super Fund and a member of its Audit and Insurance Committee). Peter is a former board member of the Royal Adelaide Hospital Inc.

Peter was a commissioner of the South Australian Lotteries Commission (Past Chair of the Audit Committee). Peter is a director of public companies: Vet Biotechnology Ltd, SDP Technology Ltd, Ascend Asset Management Ltd and LabTech Systems Ltd.

Catherine (Kate) Mary Costello LLB
Kate has a law degree from the University of Melbourne and was previously an academic at the University of South Australia. She was in management with a commercial law firm before establishing a management consultancy. Kate has 20 years experience in corporate governance and strategy through her consulting work with the boards of client organisations, her directorships and her previous involvement as a facilitator in the Company Directors’ Course offered by the Australian Institute of Company Directors.

Kate’s board experience includes directorships in South Australian Totalisator Agency Board, Australian Central Credit Union Ltd, Festival City Broadcasters Ltd and chairmanship of Saab Intelligent Transport Systems and Bassett Consulting Engineers. She is currently a director of LabTech Systems Ltd, Integrated Research Ltd and Saab Systems, and a member of the Independent Selection Committee, University of Adelaide.

Lusia Halina Guthrie BAppSc MScSTC
Lusia holds a Masters degree in Science and Technology Commercialisation from the University of Adelaide and a Bachelor of Applied Science in Medical Technology from the University of South Australia. She has executive level operations and manufacturing management experience with a major international pharmaceutical company. Areas of expertise include product development, production and supply chain management, project management, industrial relations and regulatory compliance.

She has completed the Australian Institute of Company Directors program and has held several non-executive Board appointments. Recently, Lusia worked in intellectual property management and commercialisation for a leading Adelaide research institute. She is the CEO and Managing Director of LabTech Systems Ltd.